BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/23/2016 9:36:00 PM | Browse: 1520 | Download: 2662
Publication Name World Journal of Diabetes
Manuscript ID 23192
Country Japan
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Review
Article Title Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation
Manuscript Source Invited Manuscript
All Author List Kei Nakajima
Funding Agency and Grant Number
Corresponding Author Kei Nakajima, MD, PhD, Department of Metabolism, Kuki General Hospital, 418-1 Kamihayami, Kuki, Saitama 346-8530, Japan. keinaka@josai.ac.jp
Key Words Serum amylase; Salivary; Pancreas; Diabetes; Metabolic syndrome; Obesity; AMY1; AMY2; Insulin resistance
Core Tip Low serum amylase was believed to occur in uncommon conditions such as type 1 diabetes, advanced chronic pancreatitis, and cystic fibrosis. However, in the last decade, low serum amylase has been observed in more common conditions related with insulin resistance than was previously believed. In this review, a novel interpretation for low serum, salivary, and pancreatic amylase is discussed, particularly in terms of the cardiometabolic conditions of obesity, diabetes, and metabolic syndrome.
Publish Date 2016-03-23 21:36
Citation Nakajima K. Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation. World J Diabetes 2016; 7(6): 112-121
URL http://www.wjgnet.com/1948-9358/full/v7/i6/112.htm
DOI http://dx.doi.org/10.4239/wjd.v7.i6.112
Full Article (PDF) WJD-7-112.pdf
Full Article (Word) WJD-7-112.doc